This brand name is authorized in Turkey
The drug ETOPLUS contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Etodolac
UNII 2M36281008 - ETODOLAC
|
|
Etodolac is a non-steroidal anti-inflammatory drug (NSAID). Studies in-vitro and in human cell models have confirmed that etodolac is selective for the inhibition of COX-2. Experiments have shown etodolac to have marked anti-inflammatory activity, being more potent than several clinically established NSAIDs. |
|
2
Thiocolchicoside
UNII T1X8S697GT - THIOCOLCHICOSIDE
|
|
Thiocolchicoside is a semisynthetic sulphide derivative of colchicoside, showing muscle relaxant pharmacological activity. In vitro thiocolchicoside binds solely with gaba receptors and glycinergic stricnine sensitive.Tivozanib |
|
3
Famotidine
UNII 5QZO15J2Z8 - FAMOTIDINE
|
|
Famotidine is a potent competitive H2-receptor antagonist. Famotidine has a rapid onset of action and, at the recommended doses, has a long duration of action and is highly effective at relatively low blood concentrations. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M03BX55 | M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: TR | ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu | Identifier(s): 8699541095396 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
